LUCD
Lucid Diagnostics IncNASDAQHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$195.90M
P/E Ratio
—
EPS
$-0.69
Beta
1.25
52W High
$1.70
52W Low
$0.95
50-Day MA
$1.29
200-Day MA
$1.17
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Lucid Diagnostics Inc
Lucid Diagnostics Inc. is a commercial stage medical diagnostic technology company. The company is headquartered in New York, New York.
Fundamentals
| Revenue (TTM) | $4.71M |
| Gross Profit (TTM) | $-1.96M |
| EBITDA | $-48.77M |
| Operating Margin | -932.00% |
| Return on Equity | -711.00% |
| Return on Assets | -87.20% |
| Revenue/Share (TTM) | $0.05 |
| Book Value | $-0.33 |
| Price-to-Book | 2.16 |
| Price-to-Sales (TTM) | 41.63 |
| EV/Revenue | 52.07 |
| EV/EBITDA | -0.68 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 25.60% |
| Shares Outstanding | $188.36M |
| Float | $125.70M |
| % Insiders | 25.92% |
| % Institutions | 17.20% |
Historical Volatility
HV 10-Day
107.99%
HV 20-Day
94.99%
HV 30-Day
79.98%
HV 60-Day
67.26%
HV Rank
70.2%
Volatility is currently expanding
Analyst Ratings
Consensus ($4.10 target)
2
Strong Buy3
BuyData last updated: 4/29/2026